Inve India ▾
CICIPLA

Cipla Q4 FY26 results (Jan–Mar 2026) and concall

Healthcare · Concall AI · Call held 13 May 2026

Cipla reported a strong Q4 FY26, with One India growing 15% Y-o-Y and full-year revenue reaching INR28,163 crores. North America achieved $780 million in annual revenue, securing key regulatory approvals and setting a target for $1 billion run rate by FY27 end. While full-year EBITDA margin was 21%, Q4 saw 15.2% due to investments and geopolitical factors. The company emphasized pipeline strength, strategic partnerships, and a commitment to AI-led transformation for future growth.

You’re reading a preview. Opening the full call uses 1 concall credit.

Sign in to use your monthly call allowance.

What they filed

Q4 FY26: revenue down 12.3%, net profit down 74.1% against the same quarter last year.

₹ Cr · quarterly
Line itemQ3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26
Revenue4,971 4,798 5,046 5,226 4,498 −10%4,210 −12%
EBITDA1,662 1,319 1,624 1,523 721 −57%567 −57%
Net profit1,438 1,485 1,303 1,211 617 −57%385 −74%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.